Pharmigene, Inc. (TPEX:7595)
11.45
0.00 (0.00%)
Jul 11, 2025, 9:09 AM CST
Pharmigene Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -82.86 | -72.65 | -42.72 | -23.43 | -11.21 | Upgrade |
Depreciation & Amortization | 23.69 | 22.81 | 19.65 | 15.02 | 11.96 | Upgrade |
Other Amortization | 0.29 | 0.06 | 0.12 | 0.18 | 0.15 | Upgrade |
Loss (Gain) From Sale of Assets | -0 | - | -0.4 | - | -0.83 | Upgrade |
Asset Writedown & Restructuring Costs | -0.13 | 2.05 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -14.46 | 0.51 | -0.21 | - | - | Upgrade |
Loss (Gain) on Equity Investments | 4.51 | 4.6 | 0.72 | 1.44 | - | Upgrade |
Stock-Based Compensation | - | - | - | - | 0.07 | Upgrade |
Provision & Write-off of Bad Debts | 3.95 | 0.07 | 0.59 | -1.44 | 1.41 | Upgrade |
Other Operating Activities | -0.28 | 0.45 | -0.09 | 1.76 | 3.19 | Upgrade |
Change in Accounts Receivable | 7.37 | 0.94 | -9.18 | -2.6 | -4.67 | Upgrade |
Change in Inventory | -26.24 | 1.13 | -9.87 | -7.73 | -10.39 | Upgrade |
Change in Accounts Payable | 6.47 | 0.76 | 4.32 | -0.01 | 1.51 | Upgrade |
Change in Unearned Revenue | 1.71 | -7.05 | 6.33 | -1.16 | -3.88 | Upgrade |
Change in Other Net Operating Assets | 5.94 | -6.21 | 7.28 | -1.33 | -0.09 | Upgrade |
Operating Cash Flow | -44.82 | -77.54 | -23.47 | -19.31 | -12.78 | Upgrade |
Capital Expenditures | -64.6 | -665.31 | -10.5 | -12.67 | -8.85 | Upgrade |
Sale of Property, Plant & Equipment | 2.12 | - | 0.93 | - | 6.02 | Upgrade |
Sale (Purchase) of Intangibles | -2.38 | -2.5 | -0.08 | -6 | -0.18 | Upgrade |
Investment in Securities | 87.02 | 9.27 | 19.1 | -62.83 | -65.17 | Upgrade |
Other Investing Activities | -1.07 | 1.11 | -4.55 | -0.78 | -5.38 | Upgrade |
Investing Cash Flow | 21.1 | -657.43 | 4.9 | -82.28 | -73.56 | Upgrade |
Short-Term Debt Issued | 12 | 70 | - | - | - | Upgrade |
Long-Term Debt Issued | 51 | 559.4 | - | - | - | Upgrade |
Total Debt Issued | 63 | 629.4 | - | - | - | Upgrade |
Short-Term Debt Repaid | -12 | -70 | - | - | - | Upgrade |
Long-Term Debt Repaid | -4.03 | -7.2 | -7.01 | -6.89 | -6.73 | Upgrade |
Total Debt Repaid | -16.03 | -77.2 | -7.01 | -6.89 | -6.73 | Upgrade |
Net Debt Issued (Repaid) | 46.97 | 552.2 | -7.01 | -6.89 | -6.73 | Upgrade |
Issuance of Common Stock | - | 175 | - | - | 259.95 | Upgrade |
Other Financing Activities | 0.31 | -0.56 | -2.17 | - | 0.5 | Upgrade |
Financing Cash Flow | 47.28 | 726.65 | -9.18 | -6.89 | 253.73 | Upgrade |
Foreign Exchange Rate Adjustments | 0.25 | -0 | 0.32 | -0.01 | 0.06 | Upgrade |
Net Cash Flow | 23.81 | -8.33 | -27.43 | -108.49 | 167.45 | Upgrade |
Free Cash Flow | -109.42 | -742.85 | -33.96 | -31.98 | -21.63 | Upgrade |
Free Cash Flow Margin | -93.90% | -559.76% | -25.38% | -24.72% | -21.34% | Upgrade |
Free Cash Flow Per Share | -2.17 | -16.33 | -0.78 | -0.74 | -0.64 | Upgrade |
Cash Interest Paid | 11.97 | 7.08 | 0.2 | 0.31 | 0.36 | Upgrade |
Cash Income Tax Paid | 0.19 | 0.09 | 0.02 | 1.12 | 0.02 | Upgrade |
Levered Free Cash Flow | -96.7 | -719.91 | -19.55 | -24.35 | -18.38 | Upgrade |
Unlevered Free Cash Flow | -89.13 | -714.97 | -19.43 | -24.16 | -18.16 | Upgrade |
Change in Net Working Capital | -7.13 | 33.04 | 0.83 | 6.47 | 12.64 | Upgrade |
Updated Aug 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.